Story thread · 2 reports / 2 sources
Novo Starts Testing Low-Dose Wegovy Pills in New Obesity Study
bloomberg.com · 9h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Novo Nordisk A/S is testing small doses of its blockbuster Wegovy pill in a new study that will help establish how low patients can go in their dose and still lose weight.
The coverage
- Novo begins study to find lowest effective dose for Wegovy pill
reuters.com · 6h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.